Related Experiment Video

Updated: May 31, 2026

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

The Generation of Therapeutic Fc Fusion Proteins to Trap Both IL-4 and IL-13

Shunichi Miyazaki, Ayako Kaitani, Kumi Izawa

    Juntendo Medical Journal
    |May 29, 2026
    PubMed

    Keywords:
    Fc fusion proteinIL-13IL-4cytokine traptype 2 inflammation

    More Related Videos

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies04:47

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

    Published on: February 23, 2018

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells09:12

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

    Published on: June 14, 2024

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...